The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Grodnitskaia E.É.

Tsentr planirovaniia sem'i i reproduktsii Departamenta zdravookhraneniia, Moskva

Kurtser M.A.

Tsentr planirovaniia sem'i i reproduktsii DZ Moskvy

The role of amh in the pathogenesis and diagnosis of polycystic ovary syndrome

Authors:

Grodnitskaia E.É., Kurtser M.A.

More about the authors

Journal: Russian Journal of Human Reproduction. 2013;(1): 42‑47

Views: 2755

Downloaded: 45

Download PDF (RU)
Contact the author
Table of contents

THE ROLE OF AMH IN THE PATHOGENESIS AND DIAGNOSIS OF POLYCYSTIC OVARY SYNDROME
THE ROLE OF AMH IN THE PATHOGENESIS AND DIAGNOSIS OF POLYCYSTIC OVARY SYNDROME

To cite this article:

Grodnitskaia EÉ, Kurtser MA. The role of amh in the pathogenesis and diagnosis of polycystic ovary syndrome. Russian Journal of Human Reproduction. 2013;(1):42‑47. (In Russ.)

Подписка 2025-2 (Russian Journal of Human Reproduction)
 
МСФ на ЯМ
Close metadata

Serum and follicular fluid antimüllerian hormone (AMH) levels have been found to be increased in women with PCOS compared to women with normal ovaries. Serum concentration correlates with the severity of symptoms. AMH appears to have a major inhibitory role during folliculogenesis, which may contribute to anovulation in PCOS. Androgen excess, hyperinsulinemia, and an intrinsic over-expression of the AMH gene are candidates for causing the increased production of AMH in PCOS. Serum AMH level is an accurate reflection of the ovarian early antral follicle number, that why it could be a diagnostic marker of PCOS.

Keywords:

PCOS
PCOS
AMH
AMH
anovulation
anovulation

Authors:

Grodnitskaia E.É.

Tsentr planirovaniia sem'i i reproduktsii Departamenta zdravookhraneniia, Moskva

Kurtser M.A.

Tsentr planirovaniia sem'i i reproduktsii DZ Moskvy

List of references:

  1. Amer S.A., Li T.C., Ledger W.L. The value of measuring anti-Mullerian hormone in women with anovulatory polycystic ovary syndrome undergoing laparoscopic ovarian diathermy. Hum Reprod 2009; 24: 11: 2760-2766.
  2. Carlsen S.M., Vanky E., Fleming R. Anti-Mullerian hormone concentrations in androgen-suppressed women with polycystic ovary syndrome. Human Reprod 2009; 24: 1732-1738.
  3. Carlsson I.B., Scott J.E., Visser J.A., Ritvos O., Themmen A.P., Hovatta O. Anti-Müllerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro. Hum Reprod 2006; 21: 9: 2223-2227.
  4. Carmina E., Campagna A.M., Mansuet P., Vitale G., Kort D., Lobo R. Does the level of serum antimüllerian hormone predict ovulatory function in women with polycystic ovary syndrome with aging? Fertil Steril 2012; 98: 4: 1043-1046.
  5. Catteau-Jonard S., Jamin S.P., Leclerc A., Gonzalès J., Dewailly D., di Clemente N. Anti-Mullerian hormone, its receptor, FSH receptor, and androgen receptor genes are overexpressed by granulosa cells from stimulated follicles in women with polycystic ovary syndrome. J Clin Endocrinol Metabol 2008; 93: 11: 4456-4461.
  6. Conway G.S., Jacobs H.S. Clinical implications of hyperinsulinaemia in women. Clin Endocrinol (Oxford) 1993; 39: 6: 623-632.
  7. Das M., Gillott D.J., Saridogan E., Djahanbakhch O. Anti-Müllerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary sundrome. Human Reprod 2008; 23: 2122-2126.
  8. Desforges-Bullet V., Gallo C., Lefebvre C., Pigny P., Dewailly D., Catteau-Jonard S. Increased anti-Müllerian hormone and decreased FSH levels in follicular fluid obtained in women with polycystic ovaries at the time of follicle puncture for in vitro fertilization. Fertil Steril 2010; 94: 1: 198-204.
  9. Dewailly D., Gronier H., Poncelet E., Robin G., Leroy M., Pigny P., Duhamel A., Catteau-Jonard S. Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries. Hum Reprod 2011; 26: 11: 3123-3129.
  10. Dunaif A., Mandeli J., Fluhr H., Dobrjansky A. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome. J Clin Endocrinol Metabol 1988; 66: 1: 131-139.
  11. Durlinger A.L., Gruijters M.J., Kramer P., Karels B., Kumar T.R., Matzuk M.M., Rose U.M., de Jong F.H., Uilenbroek J.T., Grootegoed J.A., Themmen A.P. Anti-Müllerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology 2001; 142: 11: 4891-4899.
  12. Eldar-Geva T., Margalioth E.J., Gai M., Ben-Chetrit A., Algur N., Zylber-Haran E., Brooks B., Huerta M., Spitz I.M. Serum anti-Mullerianhormone levels during controlled ovarian hyperstimulation in women inpolycystic ovaries with and without hyperandrogenism. Human Reprod 2005; 20: 1814-1819.
  13. El-Halawaty S., Rizk A., Kamal M., Aboulhassan M., Al-Sawah H., Noah O., Al-Inany H. Clinical significance of serum concentration of anti-Müllerian hormone in obese women with polycystic ovary syndrome. Reprod Biomed Online 2007; 15: 495-499.
  14. Falbo A., Rocca M., Russo T., D'Ettore A., Tolino A., Zullo F., Orio F., Palomba S. Serum and follicular anti-Mullerian hormone levels in women with polycystic ovary syndrome (PCOS) under metformin. J Ovarian Res 2010; 3: 16.
  15. Fleming R., Harborne L., MacLaughlin D.T., Ling D., Norman J., Sattar N., Seifer D.B. Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment. Fertil Steril 2005; 83: 130-136.
  16. Gilling-Smith C., Willis D.S., Beard R.W., Franks S. Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. J Clin Endocrinol Metabol 1994; 79: 4: 1158-1165.
  17. Grossman M.P., Nakajima S.T., Fallat M.E., Siow Y. Müllerian-inhibiting substance inhibits cytochrome P450 aromatase activity in human granulosa lutein cell culture. Fertil Steril 2008; 89: 5: Suppl: 1364-1370.
  18. Hudecova M., Holte J., Olovsson M., Sundström Poromaa I. Long-term follow-up of patients with polycystic ovary syndrome:reproductive outcome and ovarian reserve. Hum Reprod 2009; 24: 5: 1176-1183.
  19. Jonard S., DeWailly D. The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. Hum Reprod Update 2004; 10: 107-117.
  20. Kevenaar M.E., Laven J.S., Fong S.L., Uitterlinden A.G., de Jong F.H., Themmen A.P., Visser J.A. A functional anti-mullerian hormone gene polymorphism is associated with follicle number and androgen levels in polycystic ovary syndrome patients. J Clin Endocrinol Metabol 2008; 93: 4: 1310-1316.
  21. Kevenaar M.E., Themmen A.P., van Kerkwijk A.J., Valkenburg O., Uitterlinden A.G., de Jong F.H., Laven J.S., Visser J.A. Variants in the ACVR1 gene are associated with AMH levels in women with polycystic ovary syndrome. Hum Reprod 2009; 24: 1: 241-249.
  22. Laven J.S.E., Mulders A.M., Visser J., Themmen A.P., de Jong F.H., Fauser B.C.J.M. Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metabol 2004; 89: 318-323.
  23. Lin Y.H., Chiu W.C., Wu C.H., Tzeng C.R., Hsu C.S., Hsu M.I. Antimüllerian hormone and polycystic ovary syndrome. Fertil Steril 2011; 96: 1: 230-235.
  24. La Marca A., Orvieto R., Giulini S., Jasonni V.M., Volpe A., De Leo V. Mullerian-inhibiting substance in women with polycystic ovary syndrome: relationship with hormonal and metabolic characteristics. Fertil Steril 2004; 82: 970-972.
  25. Moran L.J., Noakes M., Clifton P.M., Norman R.J. The use of anti-Müllerian hormone in predicting menstrual response after weight loss in overweight women with polycystic ovary syndrome. J Clin Endocrinol Metabol 2007; 92: 3796-3802.
  26. Mulders A.G., Laven J.S., Eijkemans M.J., de Jong F.H., Themmen A.P.N., Fauser B.C. Changes in anti-Mullerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility. Human Reprod 2004; 19: 2036-2042.
  27. Panidis D., Georgopoulos N.A., Piouka A., Katsikis I., Saltamavros A.D., Decavalas G., Diamanti-Kandarakis E. The impact of oral contraceptives and metformin on anti-Müllerian hormone serum levels in women withpolycystic ovary syndrome and biochemical hyperandrogenemia. Gynecol Endocrinol 2011; 27: 8: 587-592.
  28. Pellatt L., Hanna L., Brincat M., Galea R., Brain H., Whitehead S., Mason H.D. Granulosa cell production of anti-Mullerian hormone (AMH) is increased in the polycystic ovary. J Clin Endocrinol Metabol 2007; 90: 240-245.
  29. Pellatt L., Rice S., Mason H.D. Anti-Müllerian hormone and polycystic ovary syndrome: a mountain too high? Reproduction 2010; 139: 5: 825-833.
  30. Pigny P., Merlen E., Robert Y., Cortet-Rudelli C., Decanter C., Jonard S., Dewailley D. Elevated serum level of anti-Mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicle arrest. J Clin Endocrinol Metabol 2003; 88: 5957-5962.
  31. Pigny P., Jonard S., Robert Y., Dewailly D. Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J Clin Endocrinol Metabol 2006; 91: 3: 941-945.
  32. Piltonen T., Morin-Papunen L., Koivunen R., Perheentupa A., Ruokonen A., Tapanainen J.S. Serum AMH levels remain high until late reproductive age and decrease during metformin treatment in women with polycystic ovary syndrome. Hum Reprod 2005; 20: 1820-1826.
  33. Piouka A., Farmakiotis D., Katsikis I., Macut D., Gerou S., Panidis D. Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels. Am J Physiol Endocrinol Metabol 2009; 296: E238-E243.
  34. Rajpert-De Meyts E., Jørgensen N., Graem N., Müller J., Cate R.L., Skakkebaek N.E. Expression of anti-Müllerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells. J Clin Endocrinol Metabol 1999; 84: 10: 3836-3844.
  35. Rey R., Lordereau-Richard I., Carel J.C., Barbet P., Cate R.L., Roger M., Chaussain J.L., Josso N. Anti-Müllerian hormone and testosterone serum levels are inversely during normal and precocious pubertal development. J Clin Endocrinol Metabol 1993; 77: 5: 1220-1226.
  36. Rice S., Ojha K., Whitehead S., Mason H. Stage-specific expression of androgen receptor, follicle-stimulating hormone receptor, and anti-Müllerian hormone type II receptor in single, isolated, human preantral follicles: relevance to polycystic ovaries. J Clin Endocrinol Metabol 2007; 92: 3: 1034-1040.
  37. Romualdi D., De Cicco S., Tagliaferri V., Proto C., Lanzone A., Guido M. The metabolic status modulates the effect of metformin on the antimullerian hormone-androgens-insulin interplay in obese women with polycystic ovary syndrome. J Clin Endocrinol Metabol 2011; 96: 5: E821-E824.
  38. van Rooij I.A., Broekmans F.J., Scheffer G.J., Looman C.W., Habbema J.D., deJong F.H., Fauser B.J., Themmen A.P., te Velde E.R. Serum anti-Mullerianhormone levels best reflect the reproductive decline with age innormal women with proven fertility: a longitudinal study. Fertil Steril 2005; 83: 979-987.
  39. Schmidt K.L., Kryger-Baggesen N., Byskov A.G., Andersen C.Y. Anti-Müllerian hormone initiates growth of human primordial follicles in vitro. Mol Cell Endocrinol 2005; 234: 1-2: 87-93.
  40. Siow Y., Kives S., Hertweek P., Perlman S., Fallat M.E. Serum Müllerian inhibiting substance levels in adolescent girls with normal menstrual cycles or with polycystic ovary syndrome. Fertil Steril 2005; 84: 938-944.
  41. Sir Petermann T., Conder T., Mliqueo M., Echiburu B., Hitschfeld C., Cristoto N. Increased anti-Müllerian hormone serum concentrations in prepubertal daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metabol 2006; 91: 3105-3109.
  42. Skałba P., Cygal A., Madej P., Dąbkowska-Huć A., Sikora J., Martirosian G., Romanik M., Olszanecka-Glinianowicz M. Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome? Eur J Obstet Gynecol Reprod Biol 2011; 158: 2: 254-259.
  43. Somunkiran A., Yavuz T., Yucel O., Ozdemir I. Anti-Müllerian hormone levels during hormonal contraception in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2007; 134: 2: 196-201.
  44. Stubbs S.A., Hardy K., Da Silva-Buttkus P., Stark J., Webber L.J., Flanagan A.M., Themmen A.P., Visser J.A., Groome N.P., Franks S. Anti-Müllerian hormone protein expression is reduced during the initial stages of follicle development in human polycystic ovaries. J Clin Endocrinol Metabol 2005; 90: 10: 5536-5543.
  45. Tehrani F.R., Solaymani-Dodaran M., Hedayati M., Azizi F. Is polycystic ovary syndrome an exception for reproductive aging? Hum Reprod 2010; 25: 7: 1775-1781.
  46. Thomson R.L., Buckley J.D., Moran L.J., Noakes M., Clifton P.M., Norman R.J., Brinkworth G.D. The effect of weight loss on anti-Mullerian hormone levels in overweight and obese women with polycystic ovarysyndrome and reproductive impairment. Human Reprod 2009; 24: 1976-1981.
  47. Tomova A., Deepinder F., Robeva R., Kirilov G., Mechandjiev Z., Kumanov P. Anti-Müllerian hormone in women with polycystic ovary syndrome before and after therapy with metformin. Horm Metabol Res 2011; 43: 10: 723-727.
  48. Vigier B., Picard J.Y., Tran D., Legeai L., Josso N. Production of anti-Mullerian hormone: another homology between Sertoli and granulose cells. Endocrinology 1984; 144: 1315-1320.
  49. Willis D., Mason H., Gilling-Smith C., Franks S. Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. J Clin Endocrinol Metabol 1996; 81: 1: 302-309.
  50. Woo H.Y., Kim K.H., Rhee E.J., Park H., Lee M.K. Differences of the association of anti-Müllerian hormone with clinical or biochemical characteristics between women with and without polycystic ovary syndrome. Endocrinol J 2012; 59: 9: 781-790.

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.